Quinoa protein peptide with hypoglycemic effect and preparation method thereof

CN119040423APending Publication Date: 2024-11-29JILIN UNIVERSITY
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411441435.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-16
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Existing hypoglycemia-lowering drugs have side effects, low bioavailability and ineffective treatment. Find a safe, low-cost food-borne natural product with good hypoglycemia-lowering effects.

Method used

Alkaline protease, trypsin and neutral protease are used to hydrolyze quinoa protein peptides that have the effect of lowering blood sugar. By adjusting pH value and enzymatic temperature, the digestion absorption rate and bioavailability of quinoa protein are improved. .

Benefits of technology

It significantly improves the blood sugar-lowering activity of quinoa protein. The inhibition rate of α-amylase and α-glucosidase by quinoa protein peptide is higher, the molecular weight is smaller, and it is easier to be absorbed by the human body. The blood sugar-lowering effect is better than that of quinoa without hydrolyzed Macroprotein.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040423A_ABST
    Figure CN119040423A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of food processing, and discloses chenopodium quinoa protein peptide with a hypoglycemic effect and a preparation method thereof.The chenopodium quinoa protein peptide with the hypoglycemic effect is prepared through the following steps that chenopodium quinoa protein is extracted; preparing a quinoa protein aqueous solution; according to the method, the preparation process is simple and easy to implement, and energy is saved; according to the quinoa protein peptide obtained by hydrolysis of alkaline protease, the inhibition rate on alpha-amylase is 36.67%, and the inhibition rate on alpha-glucosidase is 32.45%; the chenopodium quinoa protein peptide obtained by trypsin hydrolysis has an alpha-amylase inhibition rate of 35.56%, and an alpha-glucosidase inhibition rate of 28.48%; according to the quinoa protein peptide obtained by hydrolysis of neutral protease, the inhibition rate on alpha-amylase is 40.42%, and the inhibition rate on alpha-glucosidase is 26.34%; the hypoglycemic effects of the three quinoa protein peptides are superior to those of quinoa protein which is not subjected to hydrolysis treatment.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Quinoa peptide and preparation method and application thereof

    CN109234344A

  • Hypoglycemic quinoa peptide, and preparation method and applications thereof

    CN111893157A

  • Active peptide with functions of reducing blood fat and reducing uric acid as well as preparation method and application of active peptide

    CN116064710A